Decision Layer
What to do with this topic
Use this page to decide whether bile acid / gallbladder flow belongs near the top of your follow-up list or stays in the background.
What to validate first
GGT, bilirubin, fat intolerance context
Why this topic matters
Bile acid / gallbladder flow becomes more useful when it is tied to real markers instead of isolated variants.
How to use this page
Use the decision layer first, then move into genes, biomarkers, and related symptom pages only if the topic still looks relevant.
Why It Rises Or Falls
How this topic earns attention
What this topic can explain
Add a bile-flow pathway so fat intolerance and hepatic clearance strain are not buried inside broad lipid content.
What usually moves it up the list
Bile acid / gallbladder flow rises when ABCB11 and the supporting genes point in a coherent direction, and when the follow-up markers are practical enough to check early.
What usually keeps it in the background
A topic stays lower when the signal depends too heavily on symptoms alone or when other pathways show stronger, more testable drivers.
Validation markers commonly worth checking
GGT
bilirubin
fat intolerance context
Sample Report View
How Bile acid / gallbladder flow appears in the sample report
ABCB11 is the main reason bile acid / gallbladder flow rises in the sample report. Additional context comes from ABCG8, CYP7A1, SLC10A1.
High follow-up priority
GGT
This topic belongs near the top of the follow-up list because the signal is concentrated and testable.